| Literature DB >> 28448552 |
Sebastian Naour1,2, Brisa M Espinoza1,2, Jorge E Aedo1,2, Rodrigo Zuloaga1,2, Jonathan Maldonado3, Macarena Bastias-Molina4, Herman Silva3, Claudio Meneses4, Cristian Gallardo-Escarate2,5, Alfredo Molina1,2,6, Juan Antonio Valdés1,2,6.
Abstract
Teleosts exhibit a broad divergence in their adaptive response to stress, depending on the magnitude, duration, and frequency of stressors and the species receiving the stimulus. We have previously reported that the red cusk-eel (Genypterus chilensis), an important marine farmed fish, shows a physiological response to stress that results in increased skeletal muscle atrophy mediated by over-expression of components of the ubiquitin proteasome and autophagy-lysosomal systems. To better understand the systemic effects of stress on the red cusk-eel metabolism, the present study assessed the transcriptomic hepatic response to repetitive handling-stress. Using high-throughput RNA-seq, 259 up-regulated transcripts were found, mostly associated with angiogenesis, gluconeogenesis, and triacylglyceride catabolism. Conversely, 293 transcripts were down-regulated, associated to cholesterol biosynthesis, PPARα signaling, fatty acid biosynthesis, and glycolysis. This gene signature was concordant with hepatic metabolite levels and hepatic oxidative damage. Moreover, the increased plasmatic levels of AST (aspartate aminotransferase), ALT (alanine aminotransferase) and AP (alkaline phosphatase), as well as liver histology suggest stress-induced liver steatosis. This study offers an integrative molecular and biochemical analysis of the hepatic response to handling-stress, and reveals unknown aspects of lipid metabolism in a non-model teleost.Entities:
Mesh:
Year: 2017 PMID: 28448552 PMCID: PMC5407771 DOI: 10.1371/journal.pone.0176447
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Hepatic metabolites levels of glycogen, triglyceride, cholesterol and non-esterified fatty acids (NEFA).
All data are represented as means ± SEM (n = 4). Significant differences between control and stressed groups are shown as * (P < 0.05) and ** (P < 0.01).
Over-represented functional categories in clusters of up-regulated transcripts in response to handling stress.
| GO category | GO Term | GO ID | Genes Count | P_Value |
|---|---|---|---|---|
| Biological Process | vasculature development | GO:0001944 | 21 | 2.1E-9 |
| Biological Process | blood vessel development | GO:0001568 | 20 | 8.6E-9 |
| Biological Process | blood vessel morphogenesis | GO:0048514 | 17 | 1.8E-7 |
| Biological Process | angiogenesis | GO:0001525 | 10 | 5.0E-4 |
| Biological Process | cell migration | GO:0016477 | 16 | 2.7E-5 |
| Biological Process | cell motion | GO:0006928 | 21 | 5.1E-5 |
| Biological Process | cell motility | GO:0048870 | 16 | 9.0E-5 |
| Biological Process | localization of cell | GO:0051674 | 16 | 9.0E-5 |
| Molecular Function | heparin binding | GO:0008201 | 11 | 2.0E-6 |
| Molecular Function | glycosaminoglycan binding | GO:0005539 | 11 | 3.1E-5 |
| Molecular Function | polysaccharide binding | GO:0030247 | 11 | 7.1E-5 |
| Molecular Function | pattern binding | GO:0001871 | 11 | 7.1E-5 |
| Molecular Function | carbohydrate binding | GO:0030246 | 13 | 4.8E-3 |
| Biological Process | response to hormone stimulus | GO:0009725 | 19 | 1.7E-5 |
| Biological Process | response to endogenous stimulus | GO:0009719 | 20 | 1.8E-5 |
| Biological Process | response to organic substance | GO:0010033 | 27 | 5.3E-5 |
| Biological Process | response to steroid hormone stimulus | GO:0048545 | 12 | 2.0E-4 |
| Biological Process | cellular response to hormone stimulus | GO:0032870 | 9 | 1.1E-3 |
| Biological Process | response to peptide hormone stimulus | GO:0043434 | 8 | 1.0E-2 |
Over-represented functional categories in clusters of down-regulated transcripts in response to handling stress.
| GO category | GO Term | GO ID | Genes Count | P_Value |
|---|---|---|---|---|
| Biological process | steroid metabolic process | GO:0008202 | 31 | 1.2E-19 |
| Biological process | sterol metabolic process | GO:0016125 | 24 | 1.2E-19 |
| Biological process | sterol biosynthetic process | GO:0016126 | 17 | 1.4E-19 |
| Biological process | cholesterol metabolic process | GO:0008203 | 21 | 8.6E-17 |
| Biological process | cholesterol biosynthetic process | GO:0006695 | 14 | 8.8E-17 |
| Biological process | steroid biosynthetic process | GO:0006694 | 20 | 3.0E-16 |
| Biological process | lipid biosynthetic process | GO:0008610 | 33 | 1.4E-15 |
| Cellular Component | endoplasmic reticulum | GO:0005783 | 53 | 4.0E-13 |
| Cellular Component | endoplasmic reticulum part | GO:0044432 | 28 | 1.5E-10 |
| Cellular Component | nuclear envelope-endoplasmic reticulum network | GO:0042175 | 21 | 2.2E-7 |
| Cellular Component | endoplasmic reticulum membrane | GO:0005789 | 20 | 4.2E-7 |
| Cellular Component | organelle membrane | GO:0031090 | 43 | 2.3E-6 |
| Cellular Component | endomembrane system | GO:0012505 | 29 | 4.1E-4 |
| Molecular Function | monocarboxylic acid binding | GO:0033293 | 11 | 2.3E-8 |
| Molecular Function | carboxylic acid binding | GO:0031406 | 16 | 2.5E-8 |
| Molecular Function | fatty acid binding | GO:0005504 | 9 | 2.1E-7 |
| Molecular Function | acyl-CoA binding | GO:0000062 | 5 | 1.3E-4 |
| Cellular Component | microsome | GO:0005792 | 20 | 5.8E-8 |
| Cellular Component | vesicular fraction | GO:0042598 | 20 | 9.2E-8 |
| Cellular Component | cell fraction | GO:0000267 | 39 | 5.3E-5 |
| Cellular Component | membrane fraction | GO:0005624 | 25 | 1.1E-2 |
| Cellular Component | insoluble fraction | GO:0005626 | 25 | 1.7E-2 |
Fig 2Quantitative real time PCR validation of differentially expressed transcripts.
Expression of fold changes measured by RNA-seq and qPCR are indicated in the grey and black columns, respectively. agtr2 (type-2 angiotensin ii receptor), anxa2 (annexin a2), cav1 (caveolin-1), ctgf (connective tissue growth factor precursor), jun (transcription factor ap-1), lepr (leptin receptor precursor), plat (tissue-type plasminogen activator precursor), plxnd1 (plexin-b2 precursor), pkd1 (polycystin-1 precursor), s1pr1 (sphingosine 1-phosphate receptor 1), thbs1 (thrombospondin-2 precursor), tgfbr3 (transforming growth factor beta receptor type 3 precursor), hmgcr (3-hydroxy-3-methylglutaryl-coenzyme a reductase), hmgcs1 (hydroxymethylglutaryl- cytoplasmic), dhcr7 (7-dehydrocholesterol reductase), nsdhl (sterol-4-alpha-carboxylate 3- decarboxylating), acat2 (acetyl-CoA acetyltransferase), c14orf1 (ergosterol biosynthetic protein), cyp51a1 (lanosterol 14-alpha demethylase), cyb5r3 (nadh-cytochrome b5 reductase 3), fdps (farnesyl pyrophosphate synthase), tecr (trans- enoyl- reductase), hsd17b7 (3-keto-steroid reductase), idi1 (isopentenyl-diphosphate delta-isomerase 1), lss (lanosterol synthase), mvd (diphosphomevalonate decarboxylase), fau (40S ribosomal protein). Significant differences between the control and stressed groups are shown as * (P < 0.05) and ** (P < 0.01).
Fig 3Hepatic levels of lipid peroxidation, protein carbonylation and DNA oxidative damage.
All data are represented as means ± SEM (n = 4). Significant differences between control and stressed groups are shown as * (P < 0.05) and ** (P < 0.01).
Fig 4Plasmatic levels of ALT (alanine aminotransferase), AST (aspartate aminotransferasa), and AP (alkaline phosphatase).
All data are represented as means ± SEM (n = 4). Significant differences between control and stressed groups are shown as * (P < 0.05) and ** (P < 0.01).